AVITA ( RCEL ) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the Firm - AVITA Medical ( NASDAQ:RCEL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita ( RCEL ) To Contact Him Directly To Discuss Their Options Click here to participate in the action. NEW YORK, Oct. 03, 2025 ( GLOBE NEWSWIRE ) --
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
CMS grants NTAP for RECELL, adding up to $4,875 reimbursement for non-burn acute wounds, easing hospital costs and expanding patient access.
Securities Fraud Investigation Into AVITA Medical, Inc. ( RCEL ) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - AVITA Medical ( NASDAQ:RCEL )
LOS ANGELES, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of AVITA Medical, Inc. ( "Avita" or the "Company" ) ( NASDAQ:RCEL ) investors concerning the Company's possible violations of the ...
Securities Fraud Investigation Into AVITA Medical, Inc. ( RCEL ) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - AVITA Medical ( NASDAQ:RCEL )
LOS ANGELES, Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz continues its investigation of AVITA Medical, Inc. ( "Avita" or the "Company" ) ( NASDAQ: RCEL ) on behalf of investors concerning the Company's possible violations of federal securities laws.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL - AVITA Medical ( NASDAQ:RCEL )
NEW YORK, Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ( "Avita" or the "Company" ) RCEL. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm - AVITA Medical ( NASDAQ:RCEL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita ( RCEL ) To Contact Him Directly To Discuss Their Options
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
AVITA Medical has received the CE Mark for RECELL GO. This mark enables AVITA to begin commercializing RECELL GO across Europe.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL - AVITA Medical ( NASDAQ:RCEL )
NEW YORK, Sept. 10, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ( "Avita" or the "Company" ) RCEL. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm - AVITA Medical ( NASDAQ:RCEL )
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises AVITA Medical, Inc. ( "Avita" or "the Company" ) RCEL investors that the firm has initiated an investigation into possible ...
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm - AVITA Medical ( NASDAQ:RCEL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita ( RCEL ) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm - Coty ( NYSE:COTY ) , AVITA Medical ( NASDAQ:RCEL )
NEW YORK, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AVITA Medical, Inc. RCEL, Coty Inc. COTY, and Sensus Healthcare, Inc.
Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical's RECELL® System
Real-world data shows AVITA's RECELL System reduces hospital stays for burn patients by 36%, saving over $42,000 per patient vs. traditional grafts ...
Securities Fraud Investigation Into AVITA Medical, Inc. ( RCEL ) Continues - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - AVITA Medical ( NASDAQ:RCEL )
LOS ANGELES, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz continues its investigation of AVITA Medical, Inc. ( "Avita" or the "Company" ) RCEL on behalf of investors concerning the Company's possible violations of federal securities laws.
AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm - AVITA Medical ( NASDAQ:RCEL )
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises AVITA Medical, Inc. ( "Avita" or "the Company" ) RCEL investors that the firm has initiated an investigation into possible ...
Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors - AVITA Medical ( NASDAQ:RCEL )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against AVITA Medical, Inc. ( "AVITA" or the "Company" ) RCEL. The investigation concerns whether AVITA and/or certain of its officers have violated the federal securities laws ...
INVESTOR ALERT: Investigation of AVITA Medical, Inc. ( RCEL ) Announced by Holzer & Holzer, LLC - AVITA Medical ( NASDAQ:RCEL )
ATLANTA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether AVITA Medical, Inc. ( "AVITA" or the "Company" ) RCEL complied with federal securities laws.
AVITA Medical Successfully Completes Australian Equity Raise
• Private placement of approximately 17.2 million new CHESS Depositary Interests ( "New CDIs" ) quoted on the Australian Securities Exchange ( ASX ) • Issue price of A$1.32 per New CDI, raising approximately US$15 million ( ~A$23 million ) , with participation from new and existing Australian ...
AVITA Medical Successfully Completes Australian Equity Raise - AVITA Medical ( NASDAQ:RCEL )
Private placement of approximately 17.2 million new CHESS Depositary Interests ( "New CDIs" ) quoted on the Australian Securities Exchange ( ASX ) Issue price of A$1.32 per New CDI, raising approximately US$15 million ( ~A$23 million ) , with participation from new and existing Australian ...
AVITA Medical to Host Investor Webinar Briefing
VALENCIA, Calif., Aug. 10, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. ( ASX: AVH, NASDAQ: RCEL ) , a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by ...
AVITA Medical to Host Investor Webinar Briefing - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Aug. 10, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. ( AVHRCEL, a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief ...
Avita Medical ( RCEL ) Q2 Sales Up 21%
Avita Medical ( NASDAQ:RCEL ) , a regenerative medicine innovator focused on wound care solutions, reported earnings for Q2 2025 on August 7, 2025. The main news was that commercial revenue rose to $18.4 million a 21% increase from the prior year, but this result fell substantially below ...
Top 3 Health Care Stocks You'll Regret Missing This Quarter - Catalyst Pharmaceuticals ( NASDAQ:CPRX ) , Moleculin Biotech ( NASDAQ:MBRX )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., June 05, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) , a leading therapeutic acute wound care company delivering transformative solutions, today announced the first clinical publication evaluating Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix, ...
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
AVITA Medical's RECELL was recognized as the "Best New Technology Solution - Surgical" in the 2025 MedTech Breakthrough Awards.
AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., May 13, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) , a leading therapeutic acute wound care company delivering transformative solutions, is hosting its Acute Wound Care Showcase 2025 virtually today, May 13, 2025, at 11:00 a.m. Pacific Time.
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., April 09, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) , a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, today announced 16 abstracts to be presented at the American Burn Association ( ABA ) 2025 Annual Meeting, ...
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., April 03, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) , a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial launch of Cohealyx™, a collagen-based dermal matrix branded by AVITA Medical and ...
Does Avita Medical ( RCEL ) Have the Potential to Rally 73.72% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 73.7% in Avita Medical (RCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) , a leading therapeutic acute wound care company delivering transformative solutions, today announced that Jim Corbett, Chief Executive Officer, will present at TD Cowen's 45th Annual Health Care Conference on ...
Wall Street Analysts Predict a 52.64% Upside in Avita Medical ( RCEL ) : Here's What You Should Know
The mean of analysts' price targets for Avita Medical (RCEL) points to a 52.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on February 18, 2025 at 2:00PM PT.
AVITA Medical to Host Investor Webinar Briefing - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc.
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals - AVITA Medical ( NASDAQ:RCEL )
On Tuesday, Avita Medical, Inc. RCEL revised its revenue guidance for the fourth quarter and full year of 2024. The regenerative medicine company adjusted its projections due to slower-than-expected purchasing by hospital accounts.
AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - IonQ ( NYSE:IONQ ) , FuboTV ( NYSE:FUBO )
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Wednesday. Shares of AVITA Medical, Inc RCEL fell sharply in today's pre-market trading after the company cut its fourth-quarter commercial revenue guidance and delayed expectations for GAAP ...
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
AVITA Medical expects fourth quarter 2024 commercial revenue of approximately $18.4 million, reflecting growth of around 30% over the same period in 2023.
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - ServiceNow ( NYSE:NOW ) , Mereo BioPharma Group ( NASDAQ:MREO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Raymond James analyst Robert Majek initiated coverage on ServiceNow, Inc.
AVITA Medical Announces FDA 510 ( k ) Clearance for Cohealyx, Expanding its Addressable Market - AVITA Medical ( NASDAQ:RCEL )
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDerm Cohealyx expected to triple AVITA Medical's addressable market in burns VALENCIA, Calif., Dec. 19, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc.
AVITA Medical Announces FDA 510 ( k ) Clearance for Cohealyx, Expanding its Addressable Market
AVITA Medical announces FDA clearance for Cohealyx, a new collagen-based dermal matrix, expanding its addressable market.
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Dec. 18, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) , a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the ...
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
VALENCIA, Calif., Dec. 18, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. ( NASDAQ: RCEL, ASX: AVH ) , a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that Jim Corbett, Chief Executive Officer, ...
AVITA Medical to Announce Third Quarter 2024 Financial Results
AVITA Medical announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on November 7, 2024.
AVITA Medical to Announce Third Quarter 2024 Financial Results - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) ) , a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its third quarter 2024 financial results ...
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
AVITA Medical to present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 9:10 a.m. Eastern Time.
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc.
AVITA Medical to Host Investor Webinar Briefing - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., Aug. 08, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc.
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on August 13, 2024.
AVITA Medical to Announce Second Quarter 2024 Financial Results
AVITA Medical will report its second quarter 2024 financial results after market close on August 8 2024 and host a webcast that day at 1:30 PM PDT.
AVITA Medical to Announce Second Quarter 2024 Financial Results - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., July 11, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) ) , a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financial results ...
AVITA Medical Achieves Milestone with First Case Using RECELL GO - AVITA Medical ( NASDAQ:RCEL )
VALENCIA, Calif., June 05, 2024 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. RCELAVH ) ) , a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M.
